Share the post "Shareholding Pattern: Shareholding Pattern Sun Pharma Advanced Research Company FY(Q2-Sep 2024-2025)"
Sun Pharma Advanced Research Company has released its latest shareholding reports, covering the Second quarter and the fiscal year ending on (Q2-Sep 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
| Shareholder Name | Previous Quater Quantity(In Crores) | Current Quater Quantity(In Crores) | Previous Quater Shares(in %) | Current Quater Shares(in %) | Quater to Quater Difference |
|---|---|---|---|---|---|
| Promoters | 21.31 | 21.31 | 65.67 | 65.67 | 0 |
| Public | 11.14 | 11.14 | 31.51 | 31.95 | +0.44 % |
| DII | 0.06 | 0.07 | 0.18 | 0.23 | +0.05 % |
| FII | 0.86 | 0.70 | 2.64 | 2.15 | -0.49 % |
| Government | 0.00 | 0.00 | 0 | 0 | 0 |
Promoters shareholding remained stable, at 65.67% in both June 2024 and September 2024. This indicates that the promoters’ control over the company did not change during this period. The percentage of shares held by the public increased from 31.51% in June 2024 to 31.95% in September 2024.This change suggests that the public’s investment in the company grew during the quarter.DIIs (Domestic Institutional Investors) shareholding increased from 0.18% in June 2024 to 0.23% in September 2024 , indicating that domestic institutions increased their stake in the company by 0.05% . FIIs (Foreign Institutional Investors) shareholding decreased from 2.64% in June 2024 to 2.15% in September 2024 ,indicating that foreign institutions reduced their investments by 1.5% in the company during the quarter. This suggests a pullback in their investment .During quater from June 2024 to September 2024, Goverenment ownership remained steady at 0%.This indicates that the government’s stake in the company remained consistent during this period.
Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
| Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
|---|---|---|---|---|---|
| Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 4.017 | 4.305 | 12.38 | 13.27 | + 0.89 % |
| Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 2.119 | 1.926 | 6.53 | 5.93 | -0.6 % |
| Non Resident Indians (NRIs) | 0.189 | 0.220 | 0.58 | 0.68 | + 0.1 % |
| Bodies Corporate | 2.269 | 2.279 | 6.99 | 7.02 | + 0.03 % |
| Any Other (specify) | 0.420 | 0.428 | 1.29 | 1.32 | + 0.03 % |
| HUF | 0.205 | 0.210 | 0.63 | 0.65 | + 0.02 % |
| Body Corp-Ltd Liability Partnership | 0.212 | 0.216 | 0.65 | 0.67 | + 0.02 % |
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 0.89 %.Observations show a significant difference of -0.6 % in Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs’s financial performance between quarters.Leading the way to higher stakeholding, Non Resident Indians (NRIs) has significantly boosted stakeholding by an impressive 0.1 %.Leading the way to higher stakeholding, Bodies Corporate has significantly boosted stakeholding by an impressive 0.03 %.Leading the way to higher stakeholding, Any Other (specify) has significantly boosted stakeholding by an impressive 0.03 %.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.02 %.Leading the way to higher stakeholding, Body Corp-Ltd Liability Partnership has significantly boosted stakeholding by an impressive 0.02 %.
| Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
|---|---|---|---|---|---|
| Mutual Funds/ | 0.026 | 0.034 | 0.08 | 0.1 | + 0.02 % |
| Alternate Investment Funds | 0.028 | 0.035 | 0.09 | 0.11 | + 0.02 % |
The latest quarter saw a considerable enhancement in stakeholding for Mutual Funds/, reflecting an uptick of 0.02 % in their shares.The latest quarter saw a considerable enhancement in stakeholding for Alternate Investment Funds, reflecting an uptick of 0.02 % in their shares.
| Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
|---|---|---|---|---|---|
| Foreign Portfolio Investors Category I | 0.670 | 0.662 | 2.06 | 2.04 | -0.02 % |
| Foreign Portfolio Investors Category II | 0.187 | 0.035 | 0.58 | 0.11 | -0.47 % |
Stakeholding dwindled by -0.02 % for Foreign Portfolio Investors Category I in comparison to the preceding quarter.Stakeholding dwindled by -0.47 % for Foreign Portfolio Investors Category II in comparison to the preceding quarter.
Jhunjhunwala Rekha Rakesh, these shareholders are the Anchor investors of current and previous quarter.
[my_shortcode1 values=”Sun Pharma Advanced Research Company”]
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/NINSYS.png)
